625-04-7 Usage
General Description
4-AMINO-4-METHYL-2-PENTANONE HYDROGENOXALATE is a chemical compound that is created by combining 4-amino-4-methyl-2-pentanone and hydrogenoxalate. It is commonly used in organic synthesis and pharmaceutical research as a reagent for the synthesis of various organic compounds. 4-AMINO-4-METHYL-2-PENTANONE HYDROGENOXALATE has a wide range of applications in the production of pharmaceuticals, agrochemicals, and other fine chemicals due to its versatile chemical properties. It is considered to be a valuable building block in the synthesis of complex organic molecules and is often used in the production of pharmaceutical intermediates and specialty chemicals. Additionally, it is known for its potential as a precursor in the preparation of various drugs and bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 625-04-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,2 and 5 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 625-04:
(5*6)+(4*2)+(3*5)+(2*0)+(1*4)=57
57 % 10 = 7
So 625-04-7 is a valid CAS Registry Number.
InChI:InChI=1S/C6H13NO/c1-5(8)4-6(2,3)7/h4,7H2,1-3H3
625-04-7Relevant articles and documents
Method for preparing triacetone amine
-
Paragraph 0133-0144, (2020/07/05)
An improved method is used for preparing triacetone amine while recycling the by-products. This involves treating the crude product from triacetone amine preparation, which leads to an increase in the content of compounds which react readily with ammonia. This method enables efficient recycling of the by-products formed in the synthesis of triacetone amine.
Continuous synthesis of triacetonamine over sulfonic acid-functionalized mesoporous silicas
Tian, Jun,Chen, Ligong,Zhang, Chao,Yan, Xilong,Li, Yang
, p. 17860 - 17865 (2014/05/06)
The continuous synthesis of triacetonamine from acetone and ammonia was realized over sulfonic acid-functionalized mesoporous silicas. These catalysts were characterized by TG, XPS, BET, elemental analysis and acid-base titration. The results indicated th
Methods and compositions for treating amyloid-related diseases
-
Page/Page column 154, (2010/11/24)
Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.